Brian Pontarelli, DPM
Foot & Ankle Surgery · Providence, RINPI 1194804831
Payments from drug & device makers
Across 413 payments — averaging $35.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$6K
- Smith+Nephew$2K
- Paratek Pharmaceuticals, Inc.$823
- Musculoskeletal Transplant Foundation Inc.$739
- Stryker$606
- Zimmer Biomet$472
- plus $3K from 34 others
What the payments were for
- Travel & lodging$1,60211%
- Food & beverage$12,93689%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 157 | $6,425 |
| Smith+Nephew | 84 | $2,068 |
| Paratek Pharmaceuticals, Inc. | 38 | $823 |
| Musculoskeletal Transplant Foundation Inc. | 11 | $739 |
| Stryker(2 entities) | 8 | $606 |
| Zimmer Biomet | 14 | $472 |
| Orthofix Medical, Inc. | 16 | $376 |
| Acell, Inc. | 7 | $340 |
| Treace Medical Concepts, Inc. | 5 | $339 |
| Kerecis Limited | 3 | $296 |
| Medtronic(2 entities) | 3 | $274 |
| Integra Lifesciences Corporation | 6 | $250 |
| Amgen | 5 | $196 |
| Hikma Pharmaceuticals USA | 10 | $163 |
| Ossio Inc | 3 | $161 |
| Arthrex | 1 | $112 |
| Amniox Medical, Inc. | 1 | $98 |
| IBSA Pharma Inc. | 4 | $64 |
| Sebela Pharmaceuticals Inc. | 4 | $63 |
| Misonix Inc | 4 | $60 |
| Kairos Surgical Inc | 2 | $57 |
| Kuros Biosciences USA, Inc | 1 | $51 |
| Organogenesis Inc. | 3 | $49 |
| Bioventus LLC | 2 | $47 |
| ANI Pharmaceuticals, Inc. | 2 | $45 |
| Nevro Corp. | 2 | $41 |
| Pfizer | 2 | $38 |
| Acumed LLC | 1 | $37 |
| Lifenet Health | 2 | $29 |
| KCI USA, Inc. | 1 | $28 |
| Medline Industries LP | 2 | $26 |
| In2bones USA, LLC | 1 | $25 |
| AbbVie | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $22 |
| Derma Sciences, Inc. | 1 | $19 |
| Merz North America, Inc. | 1 | $17 |
| Convatec Inc. | 1 | $17 |
| Baudax Bio Inc. | 1 | $17 |
| Dynasplint Systems Inc. | 1 | $14 |
| Nabriva Therapeutics, PLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEOX$2,021
- CLARIX$2,021
- Stravix$540
- NUZYRA$234
- Kerecis Omega3 Wound$232
- GRAFIX PL$205
- PROstep$150
- PROPHECY$150
- EVOS MINI$150
- ILIZAROV$150
- Prokera$132
- AmnioGraft$132
- TMC NANOPLASTY SYSTEM$130
- Physio-Stim$129
- VenaSeal$117
- Grafix$115
- GrafixPL$115
- Lapiplasty System$115
- ORTHOLOC 3DI$113
- KRYSTEXXA$112
How this compares
$14,538 in reported general payments places this provider in the 85th percentile of 58 foot & ankle surgery providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuzyraOmadacycline Tosylate | 15 | $50,875 |
| SantylCollagenase Clostridium Hist. | 18 | $6,806 |
| ErtapenemErtapenem Sodium | 14 | $5,952 |
| Ketoconazole | 176 | $4,492 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 35 | $1,408 |
| Ammonium Lactate | 124 | $1,351 |
| Ciclopirox | 19 | $611 |
| Betamethasone Dipropionate | 12 | $525 |
| Gabapentin | 36 | $450 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 61 | $373 |
| Pregabalin | 29 | $315 |
| Meloxicam | 54 | $313 |
| Mupirocin | 30 | $232 |
| Ibuprofen | 19 | $227 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 31 | $195 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Paratek Pharmaceuticals, Inc.Nuzyra | $823 | $50,87515 claims |
| Smith+NephewSantyl | $2,068 | $6,80618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 58 foot & ankle surgery providers in Rhode Island.
Other foot & ankle surgery in Providence
- Christopher DigiovanniProvidence$669K
- Tejal MessanaProvidence$8K
- Mark MessanaProvidence$8K
- Erik HaniukProvidence$5K
- Traci Bologna-JillProvidence$5K
- Peter SardellaProvidence$4K
- Krysia LepoerProvidence$3K
- Michael NearyProvidence$2K
- James PascalidesProvidence$102
- Brandi KimbleProvidence$59
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.